High-throughput compound screening identifies navitoclax combined with irradiation as a candidate therapy for HPV-negative head and neck squamous cell carcinoma

Katja Tuomainen; Aini Hyytiäinen; Ahmed Al-Samadi; Philipp Ianevski; Aleksandr Ianevski; Swapnil Potdar; Laura Turunen; Jani Saarela; Sergey Kuznetsov; Wafa Wahbi; Maija Risteli; Antti Mäkitie; Outi Monni; Tuula Salo

doi:10.1038/s41598-021-94259-5

High-throughput compound screening identifies navitoclax combined with irradiation as a candidate therapy for HPV-negative head and neck squamous cell carcinoma

Katja Tuomainen, Aini Hyytiäinen, Ahmed Al-Samadi, Philipp Ianevski, Aleksandr Ianevski, Swapnil Potdar, Laura Turunen, Jani Saarela, Sergey Kuznetsov, Wafa Wahbi, Maija Risteli, Antti Mäkitie, Outi Monni, Tuula Salo

Tutkimustuotos: Artikkelijulkaisu › Artikkeli › Tieteellinen › vertaisarvioitu

Alkuperäiskieli	englanti
Artikkeli	14755
Lehti	Scientific Reports
Vuosikerta	11
Sivumäärä	10
ISSN	2045-2322
DOI - pysyväislinkit	https://doi.org/10.1038/s41598-021-94259-5
Tila	Julkaistu - 20 heinäk. 2021
OKM-julkaisutyyppi	A1 Alkuperäisartikkeli tieteellisessä aikakauslehdessä, vertaisarvioitu

Tieteenalat

3122 Syöpätaudit

Pääsy asiakirjaan

10.1038/s41598-021-94259-5Lisenssi: CC BY

s41598-021-94259-5Lopullinen julkaistu versio, 3,98 MBLisenssi: CC BY

Siteeraa tätä

Tuomainen, K., Hyytiäinen, A., Al-Samadi, A., Ianevski, P., Ianevski, A., Potdar, S., Turunen, L., Saarela, J., Kuznetsov, S., Wahbi, W., Risteli, M., Mäkitie, A., Monni, O., & Salo, T. (2021). High-throughput compound screening identifies navitoclax combined with irradiation as a candidate therapy for HPV-negative head and neck squamous cell carcinoma. Scientific Reports, 11, [14755]. https://doi.org/10.1038/s41598-021-94259-5

@article{5aabd5f3a0a541389106951888db25de,

title = "High-throughput compound screening identifies navitoclax combined with irradiation as a candidate therapy for HPV-negative head and neck squamous cell carcinoma",

keywords = "CANCER, COMBINATION, 3122 Cancers",

author = "Katja Tuomainen and Aini Hyyti{\"a}inen and Ahmed Al-Samadi and Philipp Ianevski and Aleksandr Ianevski and Swapnil Potdar and Laura Turunen and Jani Saarela and Sergey Kuznetsov and Wafa Wahbi and Maija Risteli and Antti M{\"a}kitie and Outi Monni and Tuula Salo",

year = "2021",

month = jul,

day = "20",

doi = "10.1038/s41598-021-94259-5",

language = "English",

volume = "11",

journal = "Scientific Reports",

issn = "2045-2322",

publisher = "Nature Publishing Group",

}

Tuomainen, K, Hyytiäinen, A, Al-Samadi, A, Ianevski, P, Ianevski, A , Potdar, S , Turunen, L , Saarela, J , Kuznetsov, S , Wahbi, W, Risteli, M, Mäkitie, A , Monni, O & Salo, T 2021, 'High-throughput compound screening identifies navitoclax combined with irradiation as a candidate therapy for HPV-negative head and neck squamous cell carcinoma', Scientific Reports, Vuosikerta 11, 14755. https://doi.org/10.1038/s41598-021-94259-5

High-throughput compound screening identifies navitoclax combined with irradiation as a candidate therapy for HPV-negative head and neck squamous cell carcinoma. / Tuomainen, Katja; Hyytiäinen, Aini; Al-Samadi, Ahmed et al.

julkaisussa: Scientific Reports, Vuosikerta 11, 14755, 20.07.2021.

Tutkimustuotos: Artikkelijulkaisu › Artikkeli › Tieteellinen › vertaisarvioitu

TY - JOUR

T1 - High-throughput compound screening identifies navitoclax combined with irradiation as a candidate therapy for HPV-negative head and neck squamous cell carcinoma

AU - Tuomainen, Katja

AU - Hyytiäinen, Aini

AU - Al-Samadi, Ahmed

AU - Ianevski, Philipp

AU - Ianevski, Aleksandr

AU - Potdar, Swapnil

AU - Turunen, Laura

AU - Saarela, Jani

AU - Kuznetsov, Sergey

AU - Wahbi, Wafa

AU - Risteli, Maija

AU - Mäkitie, Antti

AU - Monni, Outi

AU - Salo, Tuula

PY - 2021/7/20

Y1 - 2021/7/20

KW - CANCER

KW - COMBINATION

KW - 3122 Cancers

U2 - 10.1038/s41598-021-94259-5

DO - 10.1038/s41598-021-94259-5

M3 - Article

VL - 11

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

M1 - 14755

ER -